IGFBP7: A Potential Drug Target for Cancer, Obesity and Diabetes

Target Name: IGFBP7

NCBI ID: G3490

IGFBP7

IGFBP7: A Potential Drug Target for Cancer, Obesity and Diabetes

IGFBP7 (Internet-Gated Growth Factor B7) is a protein that plays a critical role in cell signaling and growth. It is a key regulator of the insulin-like growth factor (IGF) signaling pathway, which is a critical pathway that regulates cellular growth, differentiation, and survival. IGFBP7 is a 21-kDa protein that is expressed in most tissues of the body and is composed of two distinct isoforms, IGFBP7伪 and IGFBP7尾. Both isoforms are involved in the regulation of cellular processes such as cell growth, differentiation, and survival.

One of the significant findings of the IGFBP7 study is that it is a drug target in various diseases, including cancer, obesity, and diabetes. IGFBP7 has been shown to play a critical role in the regulation of cellular processes that are relevant to these diseases, including cell growth, differentiation, and survival. Therefore, IGFBP7 is a promising drug target for the development of new therapies for these diseases.

IGFBP7伪 is a 21-kDa protein that is composed of 115 amino acid residues. It has a unique structure that includes a catalytic domain, a transmembrane region, and a cytoplasmic domain. The catalytic domain is the region that contains the protein's catalytic activity, which is responsible for the regulation of cellular processes. The transmembrane region is the region that spans the cell membrane and is involved in the regulation of IGFBP7's intracellular signaling. The cytoplasmic domain is the region that interacts with other cellular components, including other proteins and intracellular signaling molecules.

IGFBP7尾 is a 21-kDa protein that is composed of 115 amino acid residues. It has a similar structure to IGFBP7伪 but has a different catalytic domain. The catalytic domain of IGFBP7尾 is responsible for the regulation of cellular processes, including cell growth, differentiation, and survival.

IGFBP7 is involved in the regulation of various cellular processes, including cell growth, differentiation, and survival. It is a key regulator of the insulin-like growth factor (IGF) signaling pathway, which is a critical pathway that regulates cellular growth, differentiation, and survival. IGFBP7 is a critical regulator of the IGF signaling pathway, and its dysfunction has been implicated in the development of various diseases, including cancer, obesity, and diabetes.

IGFBP7 has been shown to play a critical role in the regulation of cellular processes that are relevant to these diseases, including cell growth, differentiation, and survival. For example, studies have shown that IGFBP7 is involved in the regulation of cell growth and differentiation, and that its dysfunction is associated with the development of cancer. IGFBP7 has also been shown to play a critical role in the regulation of energy metabolism, and that its dysfunction is associated with the development of obesity and diabetes.

In addition to its role in the regulation of cellular processes, IGFBP7 has also been shown to be a potential drug target for the development of new therapies for various diseases. For example, IGFBP7 has been shown to be a potential therapeutic target for the treatment of cancer, as its dysfunction is associated with the development of cancer. IGFBP7 has also been shown to be a potential therapeutic target for the treatment of obesity and diabetes, as its dysfunction is associated with the development of these diseases.

The IGFBP7 signaling pathway is involved in the regulation of various cellular processes, including cell growth, differentiation, and survival. It is a key regulator of the insulin-like growth factor (IGF) signaling pathway, which is a critical pathway that regulates cellular growth, differentiation, and survival. IGFBP7 is a critical regulator of the IGF signaling pathway, and its dysfunction

Protein Name: Insulin Like Growth Factor Binding Protein 7

Functions: Binds IGF-I and IGF-II with a relatively low affinity. Stimulates prostacyclin (PGI2) production. Stimulates cell adhesion

The "IGFBP7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IGFBP7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets